These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6580050)

  • 21. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia.
    Miller WH; Jakubowski A; Tong WP; Miller VA; Rigas JR; Benedetti F; Gill GM; Truglia JA; Ulm E; Shirley M
    Blood; 1995 Jun; 85(11):3021-7. PubMed ID: 7756637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
    Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
    Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
    Dreosti LM; Bezwoda W; Gunter K
    Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid.
    Imaizumi M; Sato A; Koizumi Y; Inoue S; Suzuki H; Suwabe N; Yoshinari M; Ichinohasama R; Endo K; Sawai T
    Leukemia; 1994 Aug; 8(8):1301-8. PubMed ID: 7520101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Four years' experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia.
    Wu X; Wang X; Qien X; Liu H; Ying J; Yang Z; Yao H
    Am J Hematol; 1993 Jul; 43(3):183-9. PubMed ID: 8352233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infrequent alterations of the RAR alpha gene in acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines.
    Morosetti R; Grignani F; Liberatore C; Pelicci PG; Schiller GJ; Kizaki M; Bartram CR; Miller CW; Koeffler HP
    Blood; 1996 May; 87(10):4399-403. PubMed ID: 8639801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
    Limentani SA; Pretell JO; Potter D; DuBois JS; Daoust PR; Spieler PS; Miller KB
    Am J Hematol; 1994 Sep; 47(1):50-5. PubMed ID: 8042616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia.
    Muindi J; Frankel SR; Miller WH; Jakubowski A; Scheinberg DA; Young CW; Dmitrovsky E; Warrell RP
    Blood; 1992 Jan; 79(2):299-303. PubMed ID: 1309668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship.
    Chomienne C; Ballerini P; Balitrand N; Daniel MT; Fenaux P; Castaigne S; Degos L
    Blood; 1990 Nov; 76(9):1710-7. PubMed ID: 2224120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
    Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
    Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined effects of all-trans retinoic acid and granulocyte colony-stimulating factor as a differentiation induction therapy for acute promyelocytic leukemia.
    Tsurumi H; Tojo A; Takahashi T; Moriwaki H; Asano S; Muto Y
    Intern Med; 1993 Aug; 32(8):648-50. PubMed ID: 7508772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-trans retinoic acid and in vitro cytokine production by acute promyelocytic leukemia cells.
    Visani G; Tosi P; Ottaviani E; Zaccaria A; Baccini C; Manfroi S; Pastano R; Remiddi C; Morelli A; Molinari AL; Zanchini R; Tura S
    Eur J Haematol; 1996 Oct; 57(4):301-6. PubMed ID: 8982293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.
    Classen CF; Teigler-Schlegel A; Röttgers S; Reinhardt D; Döhner K; Debatin KM
    Ann Hematol; 2005 Nov; 84(12):774-80. PubMed ID: 16044313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
    Chen Z; Wang W; Pan J; Chen L; Xue Y
    Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid in acute promyelocytic leukemia: the promise and the paradox.
    Clarkson B
    Cancer Cells; 1991 Jun; 3(6):211-20. PubMed ID: 1911035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?
    Dombret H; Geiger S; Daniel MT; Glaisner S; Micléa JM; Castaigne S; Merle-Beral H; Lacombe C; Chomienne C; Degos L
    Leukemia; 1995 Sep; 9(9):1473-7. PubMed ID: 7658714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment.
    Chou WC; Tang JL; Yao M; Liang YJ; Lee FY; Lin MT; Wang CH; Shen MC; Chen YC; Tien HF
    Leukemia; 1997 Jul; 11(7):921-8. PubMed ID: 9204969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.